ArriVent BioPharma, Inc. Common Stock
NASDAQ:AVBPBiotechnology
Healthcare
$10.90 +1.40%
+$0.44 today
- Market cap
- $563.78M
- Beta
- 1.42
- P/E (TTM)
- -9.8
- EPS (TTM)
- -$3.22
52W Low $16.10High $33.62
Volume 2.70M
Average 0.50M
Price history
ArriVent BioPharma, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-45.58%
Period high
$34.74
Period low
$10.69
Latest
$10.90
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 2, 2026 | Nov 2, 2026 | |
| 8-K | Oct 26, 2026 | Oct 26, 2026 | |
| 8-K | Oct 19, 2026 | Oct 19, 2026 | |
| SC 13G | Oct 13, 2026 | Oct 13, 2026 | |
| 8-K | Oct 13, 2026 | Oct 13, 2026 | |
| SC 13D/A | Oct 8, 2026 | Oct 8, 2026 | |
| 8-K | Oct 6, 2026 | Oct 6, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G/A | Jul 27, 2026 | Jul 27, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 |
Competitors
Who does ArriVent BioPharma, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about AVBP's filings, answered from its disclosures.
What is the latest AVBP filing?
The latest filing shown is 8-K dated Nov 9, 2026.
How many recent filings does AVBP have?
Intrinsic Alpha currently shows 20 recent filings for AVBP.
Continue the stock analysis
Jump to another research area for this company.